Endoscopic Ultrasonography Eus Market Size, Share and Outlook - Growth Analysis Report and Forecast Trends 2026-2030

The EUS market includes curved linear array and radial scan endoscopes, video processors, and accessories such as fine-needle biopsy devices used for imaging-guided interventions. Private research firms estimate the 2025 global market at approximately $1.65 billion, though individual reports vary slightly in baseline year and methodology. The market remains specialized and technology-driven, with limited official government statistical tracking of commercial market values.

• •Multiple industry estimates place the 2025 global EUS market at roughly $1.65 billion
• •Projected compound annual growth rates cluster around 6.9% to 8% through the early 2030s
• •No government statistical agency publishes standard official market size figures for this niche sector

Rising prevalence of gastrointestinal, pancreatic, and pulmonary cancers has increased demand for EUS as both a diagnostic and staging tool. The technology's capacity to guide fine-needle aspiration with real-time imaging supports minimally invasive alternatives to surgical biopsy, encouraging broader clinical adoption. Aging demographics and improving healthcare infrastructure in emerging markets further sustain long-term expansion.

• •Growing incidence of gastrointestinal and pancreatic cancers drives diagnostic demand
• •Minimally invasive nature of EUS procedures supports preference over traditional surgical interventions
• •Technological improvements in imaging resolution and needle design expand clinical applications

The market is commonly divided into products including endoscopes, processors, and accessories, with biopsy needles representing a distinct and growing sub-segment. Needle segment estimates for 2025 range from approximately $162 million to $205 million depending on methodology. Geographically, North America and Europe lead due to established healthcare systems and reimbursement structures, while Asia-Pacific shows the fastest growth momentum.

• •EUS needles represent a significant sub-segment valued between $162 million and $205 million in 2025
• •North America holds the largest regional share due to high adoption rates and reimbursement support
• •Asia-Pacific is projected as the fastest-growing region driven by healthcare infrastructure development

What are the recent trends and outlook?

Market outlook through 2030-2034 centers on continued product innovation, including artificial intelligence integration for image interpretation and computer-aided lesion detection. Expansion of therapeutic EUS applications beyond diagnostics into drainage, ablation, and celiac plexus neurolysis procedures is expected to create new revenue opportunities. Long-term projections from industry analyses suggest the market could approach $2.27 billion by 2030 depending on adoption rates and regulatory approvals.

• •Integration of AI-assisted imaging and computer-aided detection is emerging as a key product differentiator
• •Therapeutic EUS applications including biliary drainage and tumor ablation are expanding beyond diagnostic use cases
• •Market projections suggest values between $2.0 billion and $2.3 billion by 2030-2034 depending on growth assumptions